COVID clinical symptoms, CT scans/X-rays should be used to rule out false negatives: Experts

Amid SARS COV-2 'variants of concern' circulating, they said RT-PCR tests do not miss mutations as the ones being used in India target more than two genes.

Published: 20th April 2021 08:32 AM  |   Last Updated: 20th April 2021 08:32 AM   |  A+A-

swab test

A health worker in PPE kit collects a swab sample from a traveller at Anand Vihar ISBT during coronavirus screening. (Photo | Parveen Negi, EPS)


NEW DELHI: Amid a staggering surge in COVID-19 cases, India's top experts on Monday said RT-PCR tests detect coronavirus in around 80 per cent of the cases, so clinical features and CT scans/chest X-rays should be used to rule out false negatives in symptomatic patients followed by a repeat test after 24 hours.

Amid SARS COV-2 'variants of concern' circulating, they said RT-PCR tests do not miss mutations as the ones being used in India target more than two genes.

According to government data till April 15, a total of 1,189 samples have tested positive for 'variants of concern' of SARS COV-2 in India which include 1,109 samples with the UK variant, 79 samples with South African variant and one sample with the Brazil variant.

Based on ICMR data, the current variants are also being picked up by the RT-PCR tests.

The RT-PCR test has sensitivity of around 80 per cent and therefore 20 per cent of the cases can still be missed out.

"Also, if the sample is not properly taken or if the test is done too early when the viral load is low, it may come out negative.

So, if a person is symptomatic, a combination of clinical features, laboratory reports, CT/chest X-ray can be used for presumptive diagnosis of COVID-19 and treatment should be started accordingly.

The test should also be repeated after 24 hours," AIIMS Director Dr Randeep Guleria told PTI.

Dr Samiran Panda, the Head of Epidemiology and Communicable Diseases at the Indian Council of Medical Research, said the mutants -- variants from the UK, Brazil and South Africa -- are not able to evade the diagnostic RT-PCR testing that is being conducted in India.

"In India, we have to be able to detect two or more genes of virus so if mutation happens on one area then the RT-PCR test kits will be able to capture it and it is capturing. However, some of the infections will remain undetected irrespective of the mutations happening," Panda said.

Moreover, all the mutants have been identified from these tests only, he said.

Clinical symptoms and CT scan reports should be the guiding factor for treatment rather than relying only on the RT-PCR test which has a sensitivity of around 80 per cent, another senior doctor said.

Even the rapid antigen test has a sensitivity of only 40 per cent, he said, adding, "So many patients will be missed if we rely only upon these tests."

India Matters


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp